Approach to the bleeding patient.
D000925:Anticoagulants / Q000009:adverse effects; D001789:Blood Group Antigens / Q000235:genetics; D004211:Disseminated Intravascular Coagulation / Q000209:etiology / Q000628:therapy; D017707:Erythrocyte Transfusion; D005112:Extracorporeal Circulation / Q000009:adverse effects; D005169:Factor VIII / Q000008:administration & dosage; D005260:Female; D005340:Fibrinogen / Q000008:administration & dosage; D006470:Hemorrhage / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007432:Intraoperative Period; D007962:Leukocytes; D008107:Liver Diseases / Q000150:complications; D010949:Plasma; D017713:Platelet Transfusion; D011183:Postoperative Complications / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000628:therapy; D065227:Transfusion Reaction; D014813:Vitamin K Deficiency / Q000150:complications
D000925:Anticoagulants; D001789:Blood Group Antigens; D005169:Factor VIII; D005340:Fibrinogen